‘Immune-inflammatory markers & clinical characteristics for outcomes in hospitalized SARS-CoV-2 infected patients of Pakistan: a retrospective analysis’

References

• Khalid A, Ali S. COVID-19 and its challenges for the healthcare system in Pakistan. Asian Bioeth Rev. 2020;12(4):551–564.
   PubMedGoogle Scholar
• Estenssoro E, Loudet CI, Ríos FG, et al. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study. Lancet Respir Med. 2021 Sep 1;9(9):989–998.
   PubMed Web of Science ®Google Scholar
• Rabaan AA, Al-Ahmed SH, Muhammad J, et al. Role of inflammatory cytokines in COVID-19 patients: a review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines (Basel). 2021;9:436. [Internet]. 2021 Apr 29 [cited 2022 May 11];9(5):436. Available from: https://www.mdpi.com/2076-393X/9/5/436/htm.
   PubMed Web of Science ®Google Scholar
• Soraya G, clinica ZU-M. 2020. Undefined. Crucial laboratory parameters in COVID-19 diagnosis and prognosis: an updated meta-analysis. Elsevier [Internet]. [cited 2022 May 12]; Available from: https://www.sciencedirect.com/science/article/pii/S0025775320303444.
   Google Scholar
• Yuan X, Huang W, Ye B, et al. Changes of hematological and immunological parameters in COVID-19 patients. Int J Hematol. 2020 Oct;112(4):553–559.
   PubMed Web of Science ®Google Scholar
• Moderbacher CR, Ramirez SI, Dan JM, et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020 Nov;183(4):996–1012.
   PubMed Web of Science ®Google Scholar
• Xu JB, Xu C, Zhang RB, et al. Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China. Sci Rep. 2020;10(1):15058. doi:10.1038/s41598-020-72164-7.
   PubMed Web of Science ®Google Scholar
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020 Apr 1;8(4):420–422.
   PubMed Web of Science ®Google Scholar
• Yao X, Li T, He Z, et al. 2020. Undefined. A pathological report of three COVID-19 cases by minimal invasive autopsies. europepmc.org [Internet]. [cited 2022 May 12]; Available from: https://europepmc.org/article/med/32172546.
   Google Scholar
• Hariyanto TI, Japar KV, Kwenandar F, et al. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: a systematic review and meta-analysis. Am J Emerg Med. 2021 Mar 1;41:110–119.
   PubMed Web of Science ®Google Scholar
• Keam S, Megawati D, Patel SK, et al. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection. Rev Med Virol. 2020 Sep;30(5). [cited 2022 May 12] Available from: /pmc/articles/PMC7404843/.
   PubMed Web of Science ®Google Scholar
• Fara A, Mitrev Z, Rosalia RA, et al. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines. Open Biol. 2020 Sep;10(9). [cited 2022 May 12] Available from: https://pubmed.ncbi.nlm.nih.gov/32961074/.
   PubMed Web of Science ®Google Scholar
• Henry BM, Aggarwal G, Wong J, et al. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: a pooled analysis. Am J Emerg Med. 2020 Sep 1;38(9):1722–1726.
   PubMed Web of Science ®Google Scholar
• Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis. 2020 Jul;96:467–474. [cited 2022 May 11] Available from: http://www.ijidonline.com/article/S1201971220303623/fulltext.
   PubMed Web of Science ®Google Scholar
• Lippi G, Cervellin G. Procalcitonin for diagnosing and monitoring bacterial infections: for or against? Clinical chemistry and laboratory medicine. Walter de Gruyter GmbH. 2018;56:1193–1195.
   Google Scholar
• Waris A, Din M, Iqbal N, et al. Evaluation of serum procalcitonin level as a biomarker for disease severity in COVID-19 patients. New Microbes New Infect. 2021;43:100922.
   PubMed Web of Science ®Google Scholar
• Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(1):S31.
   PubMed Web of Science ®Google Scholar
• Korevaar DA, Cohen JF, Reitsma JB, et al. Updating standards for reporting diagnostic accuracy: the development of STARD 2015. Res Integr Peer Rev. 2016 Jun;1(1):7. Available from: http://researchintegrityjournal.biomedcentral.com/articles/10.1186s41073-016-0014-7.
   PubMedGoogle Scholar
• Clinical lab tests by royal college of physicians and surgeons - Google Search. [cited 2023 Feb 12]. Available from: https://www.google.com/search?q = clinical+lab+tests+by+royal+college+of+physicians+and+surgeons&oq = clinical+lab+tests+by+royal+college+&aqs = chrome.2.69i57j33i160l5.18218j0j15&sourceid = chrome&ie = UTF-8#ip = 1.
   Google Scholar
• Khalid A, Ali Jaffar M, Khan T, et al. Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysis. Hematology. 2021;26(1):529–542.
   PubMed Web of Science ®Google Scholar
• Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. Wiley-Liss Inc 2020;95:834–847.
   PubMed Web of Science ®Google Scholar
• Waris A, Din M, Khalid A, et al. Evaluation of hematological parameters as an indicator of disease severity in Covid-19 patients: Pakistan’s experience. J Clin Lab Anal. 2021;35(6):e23809.
   PubMed Web of Science ®Google Scholar
• Lin S, Mao W, Zou Q, et al. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection. J Clin Lab Anal. 2021 Jan;35(1).
   Web of Science ®Google Scholar
• Asghar MS, Khan NA, Haider Kazmi SJ, et al. Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis. J Commun Hosp Intern Med Persp. 2020 Nov;10(6):514–520. doi:10.1080/20009666.2020.1816276.
   PubMed Web of Science ®Google Scholar
• Lo Tartaro D, Neroni A, Paolini A, et al. Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia. Commun Biol. 2022 Jun;5(1):590.
   PubMed Web of Science ®Google Scholar
• Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020 May;55(5).
   Web of Science ®Google Scholar
• Li X, Liu C, Mao Z, et al. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care. 2020 Dec;24(1).
   Web of Science ®Google Scholar
• Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med . 2020 May;18(1). [cited 2022 May 12]; Available from: https://pubmed.ncbi.nlm.nih.gov/32434518/.
   Web of Science ®Google Scholar
• Ciccullo A, Borghetti A, Zileri Dal Verme L, et al. Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line. Int J Antimicrob Agents. 2020 Aug;56(2):106017. doi:10.1016/j.ijantimicag.2020.106017.
   PubMed Web of Science ®Google Scholar
• Liu F, Li L, Xu M, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol. 2020 Jun;127:104370. doi:10.1016/j.jcv.2020.104370.
   PubMed Web of Science ®Google Scholar
• Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. Available from: https://pubmed.ncbi.nlm.nih.gov/32161940.
   PubMed Web of Science ®Google Scholar
• Song C-Y, Xu J, He J-Q, et al. COVID-19 early warning score: a multiparameter screening tool to identify highly suspected patients. medRxiv. 2020 Mar. 2020.03.05.20031906
   Google Scholar
• Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473–474.
   PubMed Web of Science ®Google Scholar
• Cleland DA, Eranki AP. Procalcitonin. StatPearls. 2021 Aug [cited 2022 May 12]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK539794/.
   Google Scholar
• Dolci A, Robbiano C, Aloisio E, et al. Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients. Clin Chem Lab Med. 2021 Feb 1;59(2):433–440.
   Web of Science ®Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629.
   PubMed Web of Science ®Google Scholar
• Vanhomwegen C, Veliziotis I, Malinverni S, et al. Procalcitonin accurately predicts mortality but not bacterial infection in COVID-19 patients admitted to intensive care unit. Irish J Med Sci. 1971. [Internet]. 2021 Mar 30; Available from: http://link.springer.com/10.1007s11845-020-02485-z
   Google Scholar
• Luo X, Zhou W, Yan X, et al. Prognostic value of creactive protein in patients with COVID-19 (internet). Infect Dis (Except HIV/ AIDS). 2020. doi:10.1101/2020.03.21.20040360.
   Google Scholar
• Herold T, Jurinovic V, Arnreich C, et al. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19. J Allergy Clin Immunol. 2020;146(1):128–136.e4.
   PubMed Web of Science ®Google Scholar
• Fielding CA, McLoughlin RM, McLeod L, et al. IL-6 regulates Neutrophil Trafficking during acute inflammation via STAT3. J Immunol. 2008 Aug;181(3):2189–2195. [cited 2022 May 13]; Available from: https://www.jimmunol.org/content/181/3/2189.
   PubMed Web of Science ®Google Scholar
• Grifoni E, Valoriani A, Cei F, et al. Interleukin-6 as prognosticator in patients with COVID-19. J Infect. 2020 Sep;81(3):452–482.
   PubMed Web of Science ®Google Scholar
• Chang SH, Minn D, Kim SW, et al. Inflammatory markers and cytokines in moderate and critical cases of COVID-19. Clin Lab. 2021 Sep;67(9):2115–2120.
   Web of Science ®Google Scholar
• Gao Y, Li T, Han M, et al. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020.
   Web of Science ®Google Scholar
• Aziz M, Fatima R, Assaly R. Elevated interleukin-6 and severe COVID-19: a meta-analysis. J Med Virol. 2020 Nov;92(11):2283–2285. [cited 2022 May 13] Available from: https://onlinelibrary.wiley.com/doi/full/10.1002jmv.25948.
   PubMed Web of Science ®Google Scholar
• Herold T, Jurinovic Phd V, Arnreich C, et al. Level of IL-6 predicts respiratory failure in hospitalized symptomatic COVID-19 patients. medrxiv.org [Internet]. [cited 2022 May 13]; Available from: https://www.medrxiv.org/content/10.11012020.04.01.20047381.abstract.
   Google Scholar
• Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. bmj.com [Internet]. [cited 2022 May 13]; Available from: https://www.bmj.com/content/368/bmj.m1091.
   Google Scholar
• Surbatovic M, Popovic N, Vojvodic D, et al. Cytokine profile in severe gram-positive and gram-negative abdominal sepsis. Sci Rep. 2015;5(1):11355.
   PubMedGoogle Scholar
• Calfee CS, Delucchi K, Parsons PE, et al. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med. 2014;2(8):611–620.
   PubMed Web of Science ®Google Scholar
• Famous KR, Delucchi K, Ware LB, et al. Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med. 2016;195(3):331–338.
   Web of Science ®Google Scholar
• Sinha P, Delucchi KL, Thompson BT, et al. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intens Care Med. 2018;44(11):1859–1869.
   PubMed Web of Science ®Google Scholar
• Sinha P, Delucchi KL, Thompson BT, et al. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med. 2018 Nov;44(11):1859–1869. [cited 2022 May 13]; Available from: https://link.springer.com/article/10.1007s00134-018-5378-3.
   PubMed Web of Science ®Google Scholar
• Tanaka T. 2014. MN-CSH, undefined. IL-6 in inflammation, immunity, and disease. cshperspectives.cshlp.org [Internet]. [cited 2022 May 13]; Available from: https://cshperspectives.cshlp.org/content/6/10/a016295.short.
   Google Scholar
• Tavakolpour S, Rakhshandehroo T, Wei EX, et al. Lymphopenia during the COVID-19 infection: what it shows and what can be learned. Immunol Lett. 2020 Sep 1;225:31–32.
   PubMed Web of Science ®Google Scholar
• Henry BM, Aggarwal G, Wong J, et al. Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: a pooled analysis. Am J Emerg Med. 2020 Sep;38(9):1722–1726. [cited 2022 May 12]; Available from: https://pubmed.ncbi.nlm.nih.gov/32738466/.
   PubMed Web of Science ®Google Scholar
• Hoeboer SH, Oudemans-van Straaten HM, Groeneveld AB. Albumin rather than C-reactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset fever. BMC Pulm Med. 2015 Mar 14;15:22. doi:10.1186/s12890-015-0015-1.
   PubMed Web of Science ®Google Scholar
• Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013 Sep;13(9):752–761. [Internet] [cited 2022 May 13] Available from: http://www.thelancet.com/article/S1473309913702044/fulltext
   PubMed Web of Science ®Google Scholar
• Oner AF, Bay A, Arslan S, et al. Avian Influenza A (H5N1) Infection in Eastern Turkey in 2006. [Internet]. 2009 Oct 8 [cited 2022 May 13];355(21):2179–85. Available from: https://www.nejm.org/doi/full/10.1056NEJMoa060601. https://doi.org/10.1056/NEJMoa060601
   Google Scholar
• Banchini F, Cattaneo GM, Capelli P. Serum ferritin levels in inflammation: a retrospective comparative analysis between COVID-19 and emergency surgical non-COVID-19 patients. World J Emerg Surg. 2021 Mar 8;16(1):9.
   PubMed Web of Science ®Google Scholar
• Ruscitti P, Berardicurti O, Di Benedetto P, et al. Severe COVID-19, another piece in the puzzle of the Hyperferritinemic Syndrome. An immunomodulatory perspective to alleviate the storm. Front Immunol. 2020 May;11:1130.
   PubMed Web of Science ®Google Scholar
• Colafrancesco S, Alessandri C, Conti F, et al. COVID-19 gone bad: a new character in the spectrum of the hyperferritinemic syndrome? Autoimmun Rev. 2020 Jul;19(7):102573.
   PubMed Web of Science ®Google Scholar
• Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45:486–552.
   PubMed Web of Science ®Google Scholar
• Pu SL, Zhang XY, Liu DS, et al. Unexplained elevation of erythrocyte sedimentation rate in a patient recovering from COVID-19: a case report. World J Clin Cases. 2021;9(6):1394–1401. doi:10.12998/wjcc.v9.i6.1394.
   PubMed Web of Science ®Google Scholar
• Rendeiro AF, Ravichandran H, Bram Y, et al. The spatial landscape of lung pathology during COVID-19 progression. Nature. 2021 May;593(7860):564–569.
   PubMed Web of Science ®Google Scholar